 |
|
PEP-3-KLH conjugate vaccine
A cancer vaccine consisting of PEP-3, a synthetic peptide encompassing a tumor-specific mutated segment of the epidermal growth factor receptor type vIII (EGFRvIII), conjugated to the naturally-occuring immunoadjuvant keyhole limpet hemocyanin (KLH) with potential immunostimulating and antineoplastic activities. Upon administration, PEP-3-KLH conjugate vaccine may induce a cytotoxic immune response against tumor cells that overexpress EGFRvIII; this antitumoral immune response may involve antibody-dependent cellular cytotoxicity (ADCC).
Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
| Synonym: | | PEPvIII-KLH conjugate vaccine | | | | Abbreviation: | | PEP-3-KLH | | |
|
|
